文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

超小水溶性金属-氧化铁纳米颗粒作为磁共振成像的 T1 加权造影剂。

Ultrasmall water-soluble metal-iron oxide nanoparticles as T1-weighted contrast agents for magnetic resonance imaging.

机构信息

Key Laboratory of Magnetic Materials and Devices & Division of Functional Materials and Nanodevices, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, China.

出版信息

Phys Chem Chem Phys. 2012 Feb 28;14(8):2631-6. doi: 10.1039/c2cp23196d. Epub 2012 Jan 25.


DOI:10.1039/c2cp23196d
PMID:22273844
Abstract

Using an improved hydrolysis method of inorganic salts assisted with water-bath incubation, ultrasmall water-soluble metal-iron oxide nanoparticles (including Fe(3)O(4), ZnFe(2)O(4) and NiFe(2)O(4) nanoparticles) were synthesized in aqueous solutions, which were used as T(1)-weighted contrast agents for magnetic resonance imaging (MRI). The morphology, structure, MRI relaxation properties and cytotoxicity of the as-prepared metal-iron oxide nanoparticles were characterized, respectively. The results showed that the average sizes of nanoparticles were about 4 nm, 4 nm and 5 nm for Fe(3)O(4), ZnFe(2)O(4) and NiFe(2)O(4) nanoparticles, respectively. Moreover, the nanoparticles have good water dispersibility and low cytotoxicity. The MRI test showed the strong T(1)-weighted, but the weak T(2)-weighted MRI performance of metal-iron oxide nanoparticles. The high T(1)-weighted MRI performance can be attributed to the ultrasmall size of metal-iron oxide nanoparticles. Therefore, the as-prepared metal-iron oxide nanoparticles with good water dispersibility and ultrasmall size can have potential applications as T(1)-weighted contrast agent materials for MRI.

摘要

采用改进的无机盐水相辅助水浴孵化水解法,在水溶液中合成了超小水溶性金属-铁氧化物纳米粒子(包括 Fe(3)O(4)、ZnFe(2)O(4) 和 NiFe(2)O(4)纳米粒子),用作磁共振成像(MRI)的 T(1)加权造影剂。分别对所制备的金属-铁氧化物纳米粒子的形貌、结构、磁共振弛豫性能和细胞毒性进行了表征。结果表明,Fe(3)O(4)、ZnFe(2)O(4)和 NiFe(2)O(4)纳米粒子的平均粒径分别约为 4nm、4nm 和 5nm。此外,纳米粒子具有良好的水分散性和低细胞毒性。MRI 测试表明,金属-铁氧化物纳米粒子具有较强的 T(1)加权,但较弱的 T(2)加权 MRI 性能。高 T(1)加权 MRI 性能归因于金属-铁氧化物纳米粒子的超小尺寸。因此,所制备的具有良好水分散性和超小尺寸的金属-铁氧化物纳米粒子有望作为 MRI 的 T(1)加权造影剂材料得到应用。

相似文献

[1]
Ultrasmall water-soluble metal-iron oxide nanoparticles as T1-weighted contrast agents for magnetic resonance imaging.

Phys Chem Chem Phys. 2012-1-25

[2]
Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.

Nanotechnology. 2011-4-21

[3]
Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging.

Langmuir. 2007-4-10

[4]
Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.

J Am Chem Soc. 2011-7-25

[5]
Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.

Biomaterials. 2011-3-31

[6]
Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate.

Int J Pharm. 2007-3-21

[7]
Ultrasmall manganese ferrite nanoparticles as positive contrast agent for magnetic resonance imaging.

Adv Healthc Mater. 2013-7

[8]
Relaxation behavior study of ultrasmall superparamagnetic iron oxide nanoparticles at ultralow and ultrahigh magnetic fields.

J Phys Chem B. 2011-11-10

[9]
Ultrasmall iron oxide nanoparticles for biomedical applications: improving the colloidal and magnetic properties.

Langmuir. 2011-12-2

[10]
Comparative analysis of the 1H NMR relaxation enhancement produced by iron oxide and core-shell iron-iron oxide nanoparticles.

Magn Reson Imaging. 2007-12

引用本文的文献

[1]
Preparation and characterization of various PVPylated divalent metal-doped ferrite nanoparticles for magnetic hyperthermia.

RSC Adv. 2024-5-14

[2]
Ultrasmall Mn-doped iron oxide nanoparticles with dual hepatobiliary and renal clearances for MR liver imaging.

Nanoscale Adv. 2024-3-13

[3]
Dextran mediated MnFeO/ZnS magnetic fluorescence nanocomposites for controlled self-heating properties.

RSC Adv. 2021-3-30

[4]
The Renal Clearable Magnetic Resonance Imaging Contrast Agents: State of the Art and Recent Advances.

Molecules. 2020-11-1

[5]
[T-weighted magnetic resonance imaging contrast agents and their theranostic nanoprobes].

Nan Fang Yi Ke Da Xue Xue Bao. 2020-3-30

[6]
Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus.

Philos Trans A Math Phys Eng Sci. 2017-11-28

[7]
Synthesis and In Vitro Characterization of Fe-Doped Layered Double Hydroxide Nanorings as a Potential Imageable Drug Delivery System.

Materials (Basel). 2017-9-27

[8]
Advanced Functional Nanomaterials for Theranostics.

Adv Funct Mater. 2017-1-12

[9]
The Effect of Inversion Time on the Relationship Between Iron Oxide Nanoparticles Concentration and Signal Intensity in T1-Weighted MR Images.

Iran J Radiol. 2014-5

[10]
Magnetic iron oxide nanoparticles for multimodal imaging and therapy of cancer.

Int J Mol Sci. 2013-7-31

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索